EI
MRK icon

Ethic Inc’s Merck MRK Stock Holding History

Ethic Inc’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.3M Buy
326,297
+8,152
+3% +$941K 0.61% 17
2025
Q4 		$33.5M Buy
318,145
+27,079
+9% +$2.54M 0.52% 22
2025
Q3 		$24.4M Sell
291,066
-9,582
-3% -$789K 0.4% 29
2025
Q2 		$23.8M Buy
300,648
+8,003
+3% +$636K 0.43% 32
2025
Q1 		$25.5M Buy
292,645
+5,532
+2% +$517K 0.52% 24
2024
Q4 		$28.6M Buy
287,113
+25,372
+10% +$2.62M 0.58% 18
2024
Q3 		$34.5M Sell
261,741
-19,938
-7% -$2.37M 0.87% 12
2024
Q2 		$34.9M Buy
281,679
+19,938
+8% +$2.57M 0.82% 12
2024
Q1 		$34.5M Buy
261,741
+22,504
+9% +$2.77M 0.87% 12
2023
Q4 		$26.1M Buy
239,237
+14,261
+6% +$1.48M 0.77% 13
2023
Q3 		$23.2M Buy
224,976
+17,366
+8% +$1.87M 0.81% 14
2023
Q2 		$24M Buy
207,610
+7,666
+4% +$870K 0.89% 10
2023
Q1 		$21.3M Buy
199,944
+29,903
+18% +$3.23M 0.86% 10
2022
Q4 		$18.9M Buy
170,041
+10,374
+6% +$1.06M 1.02% 7
2022
Q3 		$13.8M Buy
159,667
+17,467
+12% +$1.56M 0.93% 8
2022
Q2 		$13M Buy
142,200
+22,580
+19% +$2M 0.9% 10
2022
Q1 		$9.81M Buy
119,620
+18,534
+18% +$1.46M 0.68% 14
2021
Q4 		$7.75M Sell
101,086
-1,586
-2% -$126K 0.6% 23
2021
Q3 		$7.71M Buy
102,672
+16,262
+19% +$1.24M 0.79% 13
2021
Q2 		$6.72M Buy
86,410
+30,108
+53% +$2.24M 0.81% 15
2021
Q1 		$4.14M Buy
56,302
+11,047
+24% +$815K 0.74% 21
2020
Q4 		$3.53M Buy
45,255
+13,043
+40% +$998K 0.93% 14
2020
Q3 		$2.55M Buy
32,212
+7,161
+29% +$561K 0.98% 17
2020
Q2 		$1.85M Buy
25,051
+5,008
+25% +$377K 1.05% 14
2020
Q1 		$1.47M Buy
20,043
+1,625
+9% +$128K 1.23% 12
2019
Q4 		$1.6M Buy
+18,418
New +$1.51M 1.18% 14

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ethic Inc's MRK Position: Q1 2026 in Review

Ethic Inc increased its Merck (MRK) stake by 2.6% in Q1 2026, buying an estimated $941K and bringing the position to 326,297 shares worth $39.3M. The position accounts for 0.61% of the portfolio, ranked #17.

Ethic Inc first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ethic Inc held 326,297 shares of Merck worth $39.3M as of Q1 2026.
  • Ethic Inc bought 8,152 Merck shares in Q1 2026, an estimated $941K.
  • Merck made up 0.61% of Ethic Inc's portfolio in Q1 2026, its #17 holding.
  • Ethic Inc first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.